Related Sites:     ISRS   |   AAOE   |   EyeSmart   |   EyeCare America   |   Academy Foundation

About O.N.E. Editors' Choice

Each month, the O.N.E. Editors review leading journals to bring you concise summaries of the most clinically significant studies recently published. Some selections also include commentary from the O.N.E Editors - all recognized leaders in their subspecialty.

All Journal Studies section content represents the opinions of the contributing authors and does not imply endorsement by the American Academy of Ophthalmology.

Set Your Subspecialty
1-10 of 134 results.12345...14Next »

Plateau iris may play an important role in primary angle-closure glaucoma

Commentary By: Anna Singh, MD
Date: Nov 20, 2009
Subspecialty:

LASIK, PRK have no long-term effect on endothelial cells

Commentary By: Clark Springs, MD
Date: Nov 20, 2009
Subspecialty:

Bevacizumab after cataract surgery may improve vision in patients with nonproliferative diabetic retinopathy

Commentary By: Daniel M. Miller, MD, PhD
Date: Nov 16, 2009
Subspecialty:

Floppy eyelid syndrome linked to sleep apnea risk

Commentary By: Geva E. Mannor, MD, MPH
Date: Nov 16, 2009
Subspecialty:

Retinal vessel caliber linked to greater coronary heart disease risk in women

Commentary By: Anna Luisa Di Lorenzo, MD
Date: Nov 16, 2009
Subspecialty:

Wet AMD patients with poor initial acuity also benefit from bevacizumab treatment

Commentary By: Franco Recchia, MD
Date: Nov 13, 2009
Subspecialty:

Prospective study: Cataract surgery doesn’t increase risk of AMD progression

Commentary By: Lisa B. Arbisser, MD
Date: Nov 13, 2009
Subspecialty:

DALK may surpass PK as the preferred lamellar technique for keratoconus

Commentary By: Bennie Jeng, MD
Date: Nov 13, 2009
Subspecialty:

Bevacizumab appears to have no negative impact on blood pressure, IOP

Date: Nov 13, 2009
Subspecialty:
1-10 of 134 results.12345...14Next »